• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CVCDAP:用于癌症虚拟队列的分子和临床分析的集成平台。

CVCDAP: an integrated platform for molecular and clinical analysis of cancer virtual cohorts.

机构信息

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Center for Cancer Bioinformatics, Peking University Cancer Hospital and Institute, Beijing 100142, China.

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Gastrointestinal Cancer Center, Peking University Cancer Hospital and Institute, Beijing 100142, China.

出版信息

Nucleic Acids Res. 2020 Jul 2;48(W1):W463-W471. doi: 10.1093/nar/gkaa423.

DOI:10.1093/nar/gkaa423
PMID:32449936
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7439093/
Abstract

Recent large-scale multi-omics studies resulted in quick accumulation of an overwhelming amount of cancer-related data, which provides an unprecedented resource to interrogate diverse questions. While certain existing web servers are valuable and widely used, analysis and visualization functions with regard to re-investigation of these data at cohort level are not adequately addressed. Here, we present CVCDAP, a web-based platform to deliver an interactive and customizable toolbox off the shelf for cohort-level analysis of TCGA and CPTAC public datasets, as well as user uploaded datasets. CVCDAP allows flexible selection of patients sharing common molecular and/or clinical characteristics across multiple studies as a virtual cohort, and provides dozens of built-in customizable tools for seamless genomic, transcriptomic, proteomic and clinical analysis of a single virtual cohort, as well as, to compare two virtual cohorts with relevance. The flexibility and analytic competence of CVCDAP empower experimental and clinical researchers to identify new molecular mechanisms and develop potential therapeutic approaches, by building and analyzing virtual cohorts for their subject of interests. We demonstrate that CVCDAP can conveniently reproduce published findings and reveal novel insights by two applications. The CVCDAP web server is freely available at https://omics.bjcancer.org/cvcdap/.

摘要

最近的大规模多组学研究导致了癌症相关数据的快速积累,这为研究各种问题提供了前所未有的资源。虽然某些现有的网络服务器具有很高的价值和广泛的用途,但针对这些数据在队列水平上的再研究的分析和可视化功能并没有得到充分解决。在这里,我们提出了 CVCDAP,这是一个基于网络的平台,提供了一个现成的交互式和可定制的工具箱,用于分析 TCGA 和 CPTAC 公共数据集以及用户上传的数据集的队列水平。CVCDAP 允许在多个研究中灵活选择具有共同分子和/或临床特征的患者作为虚拟队列,并提供数十个内置的可定制工具,用于对单个虚拟队列进行无缝的基因组、转录组、蛋白质组和临床分析,以及对两个相关的虚拟队列进行比较。CVCDAP 的灵活性和分析能力使实验和临床研究人员能够通过构建和分析他们感兴趣的主题的虚拟队列,来识别新的分子机制并开发潜在的治疗方法。我们通过两个应用程序证明了 CVCDAP 可以方便地重现已发表的研究结果并揭示新的见解。CVCDAP 网络服务器可在 https://omics.bjcancer.org/cvcdap/ 免费获得。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2c5/7439093/f2f2afd8129a/gkaa423fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2c5/7439093/13501c960eac/gkaa423fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2c5/7439093/1a531b08bda1/gkaa423fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2c5/7439093/1fecb05f2871/gkaa423fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2c5/7439093/f2f2afd8129a/gkaa423fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2c5/7439093/13501c960eac/gkaa423fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2c5/7439093/1a531b08bda1/gkaa423fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2c5/7439093/1fecb05f2871/gkaa423fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2c5/7439093/f2f2afd8129a/gkaa423fig4.jpg

相似文献

1
CVCDAP: an integrated platform for molecular and clinical analysis of cancer virtual cohorts.CVCDAP:用于癌症虚拟队列的分子和临床分析的集成平台。
Nucleic Acids Res. 2020 Jul 2;48(W1):W463-W471. doi: 10.1093/nar/gkaa423.
2
POLE/POLD1 mutation in non-exonuclease domain matters for predicting efficacy of immune-checkpoint-inhibitor therapy.非外切酶结构域中的POLE/POLD1突变对预测免疫检查点抑制剂疗法的疗效至关重要。
Clin Transl Med. 2021 Sep;11(9):e524. doi: 10.1002/ctm2.524.
3
Primum non nocere: Are we ready for POLE testing in endometrial cancer?首要原则是不伤害:我们准备好进行子宫内膜癌的POLE检测了吗?
Gynecol Oncol. 2017 Nov;147(2):240-242. doi: 10.1016/j.ygyno.2017.09.015. Epub 2017 Sep 22.
4
POLE mutation combined with microcystic, elongated and fragmented (MELF) pattern invasion in endometrial carcinomas might be associated with poor survival in Chinese women.POLE 基因突变合并子宫内膜癌的微囊状、长形和碎片状(MELF)浸润模式可能与中国女性的不良生存相关。
Gynecol Oncol. 2020 Oct;159(1):36-42. doi: 10.1016/j.ygyno.2020.07.102. Epub 2020 Aug 12.
5
LinkedOmics: analyzing multi-omics data within and across 32 cancer types.LinkedOmics:在 32 种癌症类型内和类型间分析多组学数据。
Nucleic Acids Res. 2018 Jan 4;46(D1):D956-D963. doi: 10.1093/nar/gkx1090.
6
Clinical outcomes of patients with POLE mutated endometrioid endometrial cancer.POLE 突变型子宫内膜样癌患者的临床结局。
Gynecol Oncol. 2020 Jan;156(1):194-202. doi: 10.1016/j.ygyno.2019.10.028. Epub 2019 Nov 19.
7
High frequency of POLE mutations in synchronous endometrial and ovarian carcinoma.POLE 基因突变在同期子宫内膜癌和卵巢癌中的高频发生。
Hum Pathol. 2019 Mar;85:92-100. doi: 10.1016/j.humpath.2018.11.001. Epub 2018 Nov 15.
8
Molecular profiling identifies synchronous endometrial and ovarian cancers as metastatic endometrial cancer with favorable clinical outcome.分子谱分析将同步性子宫内膜和卵巢癌鉴定为具有良好临床结局的转移性子宫内膜癌。
Int J Cancer. 2020 Jul 15;147(2):478-489. doi: 10.1002/ijc.32907. Epub 2020 Feb 18.
9
Clinicopathological characteristics and prognostic value of POLE mutations in endometrial cancer: A systematic review and meta-analysis.子宫内膜癌中POLE突变的临床病理特征及预后价值:一项系统评价与Meta分析
Medicine (Baltimore). 2020 Feb;99(8):e19281. doi: 10.1097/MD.0000000000019281.
10
Clinicopathological analysis of endometrial carcinomas harboring somatic POLE exonuclease domain mutations.具有体细胞 POLE 外切酶结构域突变的子宫内膜癌的临床病理分析。
Mod Pathol. 2015 Apr;28(4):505-14. doi: 10.1038/modpathol.2014.143. Epub 2014 Nov 14.

引用本文的文献

1
Relationship between the protein expression of ARID1A, ARID1B and ARID2 with the clinicopathological characteristics of colorectal cancer.ARID1A、ARID1B和ARID2的蛋白表达与结直肠癌临床病理特征的关系
Biomed Rep. 2025 May 16;23(1):119. doi: 10.3892/br.2025.1997. eCollection 2025 Jul.
2
A systematic investigation of clear cell renal cell carcinoma using meta-analysis and systems biology approaches.采用荟萃分析和系统生物学方法对透明细胞肾细胞癌进行系统研究。
Mol Genet Genomics. 2024 Sep 16;299(1):87. doi: 10.1007/s00438-024-02180-z.
3
Bioinformatics tools and resources for cancer and application.

本文引用的文献

1
Visualizing and interpreting cancer genomics data via the Xena platform.通过Xena平台可视化和解读癌症基因组学数据。
Nat Biotechnol. 2020 Jun;38(6):675-678. doi: 10.1038/s41587-020-0546-8.
2
Pan-cancer analysis of whole genomes.泛癌症全基因组分析。
Nature. 2020 Feb;578(7793):82-93. doi: 10.1038/s41586-020-1969-6. Epub 2020 Feb 5.
3
Evaluation of POLE and POLD1 Mutations as Biomarkers for Immunotherapy Outcomes Across Multiple Cancer Types.评估POLE和POLD1突变作为多种癌症类型免疫治疗结果生物标志物的研究
癌症的生物信息学工具和资源及其应用。
Chin Med J (Engl). 2024 Sep 5;137(17):2052-2064. doi: 10.1097/CM9.0000000000003254. Epub 2024 Jul 30.
4
Exploring the Role and Prognostic Value of TMEM208 in Head and Neck Squamous Cell Carcinoma.探讨 TMEM208 在头颈部鳞状细胞癌中的作用和预后价值。
Asian Pac J Cancer Prev. 2024 Mar 1;25(3):909-919. doi: 10.31557/APJCP.2024.25.3.909.
5
The role of MAPK, notch and Wnt signaling pathways in papillary thyroid cancer: Evidence from a systematic review and meta-analyzing microarray datasets employing bioinformatics knowledge and literature.丝裂原活化蛋白激酶(MAPK)、Notch和Wnt信号通路在甲状腺乳头状癌中的作用:基于运用生物信息学知识和文献对微阵列数据集进行系统评价和荟萃分析的证据
Biochem Biophys Rep. 2023 Dec 14;37:101606. doi: 10.1016/j.bbrep.2023.101606. eCollection 2024 Mar.
6
CRUX, a platform for visualising, exploring and analysing cancer genome cohort data.CRUX是一个用于可视化、探索和分析癌症基因组队列数据的平台。
NAR Genom Bioinform. 2024 Feb 1;6(1):lqae003. doi: 10.1093/nargab/lqae003. eCollection 2024 Mar.
7
Sex differences in hepatocellular carcinoma indicated BEX4 as a potential target to improve efficacy of lenvatinib plus immune checkpoint inhibitors.肝细胞癌中的性别差异表明BEX4是提高乐伐替尼联合免疫检查点抑制剂疗效的潜在靶点。
J Cancer. 2022 Sep 6;13(11):3221-3233. doi: 10.7150/jca.73051. eCollection 2022.
8
Copy Number Variation of Circulating Tumor DNA (ctDNA) Detected Using NIPT in Neoadjuvant Chemotherapy-Treated Ovarian Cancer Patients.使用无创产前检测技术(NIPT)检测新辅助化疗治疗的卵巢癌患者循环肿瘤DNA(ctDNA)的拷贝数变异
Front Genet. 2022 Jul 22;13:938985. doi: 10.3389/fgene.2022.938985. eCollection 2022.
9
Targeting E2 ubiquitin-conjugating enzyme UbcH5c by small molecule inhibitor suppresses pancreatic cancer growth and metastasis.小分子抑制剂靶向 E2 泛素结合酶 UbcH5c 抑制胰腺癌生长和转移。
Mol Cancer. 2022 Mar 10;21(1):70. doi: 10.1186/s12943-022-01538-4.
10
Analyzing the key gene expression and prognostics values for acute myeloid leukemia.分析急性髓系白血病的关键基因表达及预后价值。
Transl Cancer Res. 2020 Nov;9(11):7284-7298. doi: 10.21037/tcr-20-3177.
JAMA Oncol. 2019 Oct 1;5(10):1504-1506. doi: 10.1001/jamaoncol.2019.2963.
4
Next-generation characterization of the Cancer Cell Line Encyclopedia.下一代癌症细胞系百科全书的特征描述。
Nature. 2019 May;569(7757):503-508. doi: 10.1038/s41586-019-1186-3. Epub 2019 May 8.
5
The International Cancer Genome Consortium Data Portal.国际癌症基因组联盟数据门户
Nat Biotechnol. 2019 Apr;37(4):367-369. doi: 10.1038/s41587-019-0055-9.
6
Tumor mutational load predicts survival after immunotherapy across multiple cancer types.肿瘤突变负荷可预测多种癌症类型免疫治疗后的生存情况。
Nat Genet. 2019 Feb;51(2):202-206. doi: 10.1038/s41588-018-0312-8. Epub 2019 Jan 14.
7
COSMIC: the Catalogue Of Somatic Mutations In Cancer.COSMIC:癌症体细胞突变目录。
Nucleic Acids Res. 2019 Jan 8;47(D1):D941-D947. doi: 10.1093/nar/gky1015.
8
Maftools: efficient and comprehensive analysis of somatic variants in cancer.Maftools:癌症体细胞变异的高效全面分析。
Genome Res. 2018 Nov;28(11):1747-1756. doi: 10.1101/gr.239244.118. Epub 2018 Oct 19.
9
Analysis and visualization of linked molecular and clinical cancer data by using Oncoscape.使用Oncoscape对相关分子和临床癌症数据进行分析与可视化。
Nat Genet. 2018 Sep;50(9):1203-1204. doi: 10.1038/s41588-018-0208-7.
10
Financial Impact of Breast Cancer in Black Versus White Women.黑人女性与白人女性乳腺癌的经济影响。
J Clin Oncol. 2018 Jun 10;36(17):1695-1701. doi: 10.1200/JCO.2017.77.6310. Epub 2018 Apr 18.